{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:18:50Z","timestamp":1789651130453,"version":"4.0.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011755","name":"National Center for Research and Development","doi-asserted-by":"publisher","award":["ENM3\/V\/16\/I2PAD\/2023"],"award-info":[{"award-number":["ENM3\/V\/16\/I2PAD\/2023"]}],"id":[{"id":"10.13039\/501100011755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["101008571"],"award-info":[{"award-number":["101008571"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.nucmedbio.2025.109595","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T16:33:29Z","timestamp":1764866009000},"page":"109595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Scandium-47 as a radionuclide precursor: Feasibility of production in a 47Ca\/47Sc generator-like system"],"prefix":"10.1016","volume":"152-153","author":[{"given":"Izabela","family":"Cieszykowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"\u017b\u00f3\u0142towska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Sochaczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Tymi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Marganiec-Ga\u0142\u0105zka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Miko\u0142ajczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2025.109595_bb0005","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.2967\/jnumed.114.141614","article-title":"Promising prospects for 44Sc\/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice","volume":"55","author":"M\u00fcller","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0010","first-page":"316","article-title":"Promising scandium radionuclides for nuclear medicine: a review on the production and chemistry up to in vivo proofs of concept","volume":"33","author":"Huclier-Markai","year":"2018","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0015","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0969-8043(98)00016-5","article-title":"Radiochemical purification of no-carrier-added Scandium-47 for Radioimmunotherapy","volume":"49","author":"Kolsky","year":"1998","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0969-8043(97)00040-7","article-title":"Radionuclide development at BNL for nuclear medicine therapy","volume":"49","author":"Mausner","year":"1998","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41181-021-00131-2","article-title":"Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements","volume":"6","author":"Miko\u0142ajczak","year":"2021","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/j.semnuclmed.2011.12.004","article-title":"Paving the way to personalised medicine: production of some promising theragnostic radionuclides at Brookhaven National Laboratory","volume":"42","author":"Srivastava","year":"2012","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1524\/ract.2012.1938","article-title":"New separation method of no-carrier-added 47Sc from titanium targets","volume":"100","author":"Bart\u00f3s","year":"2012","journal-title":"Radiochim Acta"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10967-009-0370-6","article-title":"Separation of no-carrier-added radioactive scandium from neutron irradiated titanium","volume":"283","author":"Bokhari","year":"2010","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41181-017-0024-x","article-title":"47Sc as useful \u03b2\u2212-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes","volume":"2","author":"Domnanich","year":"2017","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0050","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1080\/01496395.2017.1295994","article-title":"An electroamalgamation approach to separate 47Sc from neutron-activated 46Ca target for use in cancer theranostics","volume":"52","author":"Chakravarty","year":"2017","journal-title":"Sep Sci Technol"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.apradiso.2016.09.004","article-title":"Production and purification of Scandium-47: a potential radioisotope for cancer theranostics","volume":"118","author":"Deilami-nezhad","year":"2016","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/ract-2018-3070","article-title":"Feasibility study on production of Sc-47 from neutron irradiated ca target for cancer theranostics applications","volume":"108","author":"Gizawy","year":"2020","journal-title":"Radiochim Acta"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.apradiso.2019.05.020","article-title":"Comparison of separation methods for 47Ca\/47Sc radionuclide generator","volume":"151","author":"Pawlak","year":"2019","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0070","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.apradiso.2012.04.030","article-title":"Cyclotron produced 44gSc from natural calcium","volume":"70","author":"Severin","year":"2012","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0075","first-page":"56","article-title":"Improved procedures of Sc(OH)3 precipitation and UTEVA extraction for 44Sc separation","volume":"22","author":"Wojdowska","year":"2019","journal-title":"Nucl Med Rev"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1524\/ract.2013.2032","article-title":"Cyclotron production of 44Sc for clinical application","volume":"101","author":"Krajewski","year":"2013","journal-title":"Radiochim Acta"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10967-017-5321-z","article-title":"47Sc production development by cyclotron irradiation of 48Ca","volume":"313","author":"Misiak","year":"2017","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.apradiso.2014.09.020","article-title":"Separation of cyclotron-produced 44Sc from a natural calcium target using a dipentyl pentylphosphonate functionalized extraction resin","volume":"95","author":"Valdovinos","year":"2015","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0095","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.nucmedbio.2015.03.002","article-title":"Cyclotron production of high purity 44m,44Sc with deuterons from 44CaCO3 targets","volume":"42","author":"Alliot","year":"2015","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0100","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.2967\/jnumed.113.123810","article-title":"Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent \u03b2\u2212-emitters: in vitro and in vivo study of a 44Sc-DOTA-FOLATE conjugate","volume":"54","author":"M\u00fcller","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0105","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.nucmedbio.2015.05.005","article-title":"Cyclotron production of 44Sc: from bench to bedside","volume":"42","author":"van der Meulen","year":"2015","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40658-015-0136-x","article-title":"Cyclotron production of 43Sc for PET imaging","volume":"2","author":"Walczak","year":"2015","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071787","article-title":"Separation of 44Sc from natural calcium carbonate targets for synthesis of 44Sc-DOTATATE","volume":"23","author":"Kilian","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0120","author":"Laboratoire National Henri Becquerel"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0125","series-title":"European pharmacopeia","article-title":"Radiopharmaceutical preparations, general monograph: 0125","author":"EDQM","year":"2025"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0130","series-title":"European pharmacopeia","article-title":"Lutetium (177Lu) chloride solution for Radiolabelling, monograph: 2798","author":"EDQM","year":"2023"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0135","series-title":"European pharmacopeia","article-title":"Yttrium (90Y) chloride solution for Radiolabelling, monograph: 2803","author":"EDQM","year":"2020"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0140","author":"PRISMAP project"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0145","article-title":"A true theranostic pair \u2013 44\/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer","author":"Kumar","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0150","article-title":"Gamma-ray spectrometry measurements for quality assessment of scandium-47 produced by neutron irradiation of calcium-46","author":"Tymi\u0144ski","year":"2025","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2025.109595_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2025.112213","article-title":"Activity standardization of 47Sc by LS methods","volume":"226","author":"Marganiec-Ga\u0142\u0105zka","year":"2025","journal-title":"Appl Radiat Isot"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125006043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125006043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:32:34Z","timestamp":1777602754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805125006043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"alternative-id":["S0969805125006043"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109595","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scandium-47 as a radionuclide precursor: Feasibility of production in a 47Ca\/47Sc generator-like system","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109595"}}